Patents-Review.com
🔗 Permalink
Assignee profile:

TESARO, Inc.

City:

Waltham, Massachusetts

Country:

United States

Published Applications:

12

Last publication date:

2024-07-11

Patent Grants:

11

Last grant date:

2026-01-20

Top Inventors for applications by TESARO, Inc.

These are the the leading inventors for applications assigned to TESARO, Inc.:

Recent patent applications by TESARO, Inc.

TESARO, Inc. based in Waltham, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-07-11
US20240226082A1
Human necessities

COMBINATION THERAPIES FOR TREATING CANCER

 #2 | 2024-02-22 ✅ Patent 12,527,780 granted on 2026-01-20
US20240058319A1
Human necessities

Methods of Treating Ovarian Cancer

 #3 | 2023-04-13 ✅ Patent 12,415,855 granted on 2025-09-16
US20230111418A1
Chemistry; metallurgy

METHODS OF TREATING CANCER WITH ANTI-PD-1 ANTIBODIES

 #4 | 2022-10-06 ✅ Patent 12,597,519 granted on 2026-04-07
US20220319704A1
Physics

METHODS FOR CHARACTERIZING AND TREATING A CANCER TYPE USING CANCER IMAGES

 #5 | 2020-09-24 ✅ Patent 11,661,453 granted on 2023-05-30
US20200299387A1
Chemistry; metallurgy

Combination therapies for treating cancer with niraparib and PD-1 inhibitors

 #6 | 2020-09-17 ✅ Patent 12,156,872 granted on 2024-12-03
US20200289493A1
Human necessities

Combination therapies for treating cancer

 #7 | 2020-07-30 ✅ Patent 11,407,830 granted on 2022-08-09
US20200239574A1
Chemistry; metallurgy

Methods of treating cancer with anti-PD-1 antibodies

 #8 | 2020-02-20 ✅ Patent 11,161,834 granted on 2021-11-02
US20200055837A1
Chemistry; metallurgy

Methods of manufacturing of niraparib

 #9 | 2020-01-16 ✅ Patent 10,829,476 granted on 2020-11-10
US20200017462A1
Chemistry; metallurgy

Niraparib compositions

 #10 | 2019-10-24 ✅ Patent 11,926,665 granted on 2024-03-12
US20190322746A1
Chemistry; metallurgy

Methods of treating cancer with anti-TIM-3 antibodies

 #11 | 2019-08-22 ✅ Patent 11,155,624 granted on 2021-10-26
US20190256600A1
Chemistry; metallurgy

Antibodies directed against programmed death-1 (PD-1)

 #12 | 2018-11-01 ✅ Patent 12,383,542 granted on 2025-08-12
US20180311224A1
Human necessities

Methods of treating ovarian cancer

Also check out TESARO, INC.'s (Waltham, United States) applicant profile with 19 patent applications submitted.

AssigneeID:

162963 ⎘